General Information of This Payload
Payload ID
PAY0NIKFZ
Name
Conjugate No.135 Payload
Synonyms
Conjugate No.135 Payload
   Click to Show/Hide
Structure
Formula
C46H50N9O11P
Isosmiles
COCCOP(NC1=CC=C2C(C=CN2C(C3=CC(C4=CC=C(NC(C5=NC(NC(CCCOC6=C(OC)C=C(C7=O)C(N[C@@H](O)[C@]8([H])CC(CN87)=C)=C6)=O)=CN5C)=O)C=C4)=CN3C)=O)=C1)(O)=O
InChI
InChI=1S/C46H50N9O11P/c1-27-19-36-43(57)48-34-23-39(38(64-5)22-33(34)45(59)55(36)24-27)65-16-6-7-41(56)49-40-26-53(3)42(50-40)44(58)47-31-10-8-28(9-11-31)30-21-37(52(2)25-30)46(60)54-15-14-29-20-32(12-13-35(29)54)51-67(61,62)66-18-17-63-4/h8-15,20-23,25-26,36,43,48,57H,1,6-7,16-19,24H2,2-5H3,(H,47,58)(H,49,56)(H2,51,61,62)/t36-,43-/m0/s1
InChIKey
YQJRYRUJMAJEEJ-BIMBCEMMSA-N
Pharmaceutical Properties
Molecule Weight
935.932
Polar area
241.77
Complexity
2910.030082
xlogp Value
5.8173
Heavy Count
67
Rot Bonds
17
Hbond acc
15
Hbond Donor
6
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
WO2019126691A1 Conjugate No.135 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.02 nM
Positive HER2 expression (HER2+++/++)
Method Description
OVCAR3 cells were plated at a density of 5000 cells per well and the next day were treated with antibody-PBD conjugate for 3 days.
In Vitro Model High grade ovarian serous adenocarcinoma OVCAR3 cells CVCL_0465
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 100 nM Moderate HER2 expression (HER2++)
Method Description
JIMT1 cells were plated at a density of 5000 cells per well and the next day were treated with antibody-PBD conjugate for 3 days.
In Vitro Model Breast ductal carcinoma JIMT1 cells CVCL_2077
References
Ref 1 Pyrrolobenzodiazepine antibody conjugates